Yeah, I believe you are correct. Lot of off-label
Post# of 144836
I wonder how that fix that with the licensing deals? If they have one for HIV and a separate one for cancer. I suspect the cancer partner wouldn't like off-label sales going to the HIV partner. And it could become a considerable amount with more great cancer results in human trials.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)